Illingworth Research Group

Executive Summary

Illingworth Research Group is a UK-based clinical research services company founded in 2005, specializing in patient-centric support solutions for clinical trials in the drug delivery and medical devices sectors. The company focuses on reducing the burdens of trial participation for patients, caregivers, and research sites, thereby enhancing the overall clinical trial experience. By prioritizing participant engagement and retention, Illingworth aims to improve trial efficiency and outcomes. Despite being privately held with no disclosed financials or pipeline products, the company's niche in patient-centric services positions it well within the evolving clinical research landscape, where decentralized and patient-focused trials are gaining traction. Its long-standing presence since 2005 and established Manchester base suggest a stable, specialized operation.

Upcoming Catalysts (preview)

• Q1 2027Expansion into decentralized clinical trial services60% success
• Q4 2026Strategic partnership with a larger CRO or pharmaceutical firm40% success
• Q3 2026New regulatory incentives for patient-centric trials in the UK70% success